サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1390921

3Dバイオプリンティングの世界市場レポート 2024年

3D Bioprinting Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 200 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.76円
3Dバイオプリンティングの世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

2023年の3Dバイオプリンティング市場で最大の地域は北米です。予測期間中、アジア太平洋は3Dバイオプリンティング市場で最も急成長している地域になると予測されています。3Dバイオプリンティング市場レポート分析対象地域は、アジア太平洋、西欧、中東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 3Dバイオプリンティング市場の特徴

第3章 3Dバイオプリンティング市場の動向と戦略

第4章 3Dバイオプリンティング市場 - マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界の3Dバイオプリンティング市場規模と成長

  • 世界の3Dバイオプリンティング市場の促進要因と抑制要因
    • 市場の促進要因
    • 市場の抑制要因
  • 世界の3Dバイオプリンティング市場規模実績と成長、2018年～2023年
  • 世界の3Dバイオプリンティング市場規模と成長予測、2023年～2028年、2033年まで

第6章 3Dバイオプリンティング市場セグメンテーション

  • 世界の3Dバイオプリンティング市場、コンポーネント別セグメンテーション、実績および予測、2018年～2023年、2023年～2028年まで、2033年まで
  • 3Dバイオプリンター
  • バイオインク
  • 世界の3Dバイオプリンティング市場、材料別セグメンテーション、実績および予測、2018年～2023年、2023年～2028年まで、2033年まで
  • 生きた細胞
  • ヒドロゲル
  • 細胞外マトリックス
  • その他の材料
  • 世界の3Dバイオプリンティング市場、用途別セグメンテーション、実績および予測、2018年～2023年、2023年～2028年まで、2033年まで
  • 研究用途
  • 臨床応用
  • その他の用途
  • 世界の3Dバイオプリンティング市場、エンドユーザー別セグメンテーション、実績および予測、2018年～2023年、2023年～2028年まで、2033年まで
  • 研究機関と学術機関
  • バイオ医薬品企業
  • 病院
  • その他のエンドユーザー

第7章 3Dバイオプリンティング市場の地域および国分析

  • 世界の3Dバイオプリンティング市場、地域別、実績および予測、2018年～2023年、2023年～2028年まで、2033年まで
  • 世界の3Dバイオプリンティング市場、国別、実績および予測、2018年～2023年、2023年～2028年まで、2033年まで

第8章 アジア太平洋の3Dバイオプリンティング市場

  • 概要
  • 地域情報、COVID-19の影響、市場情報、背景情報、政府の取り組み、規制、規制機関、主要団体、課税額、法人税構造、投資、主要企業
  • コンポーネント別セグメンテーション、実績および予測、2018年～2023年、2023年～2028年まで、2033年まで
  • 用途別のセグメンテーション、実績および予測、2018年～2023年、2023年～2028年まで、2033年まで
  • エンドユーザー別のセグメンテーション、実績および予測、2018年～2023年、2023年～2028年まで、2033年まで

第9章 中国の3Dバイオプリンティング市場

第10章 インドの3Dバイオプリンティング市場

第11章 日本の3Dバイオプリンティング市場

第12章 オーストラリアの3Dバイオプリンティング市場

第13章 インドネシアの3Dバイオプリンティング市場

第14章 韓国の3Dバイオプリンティング市場

第15章 西欧の3Dバイオプリンティング市場

  • 概要
  • コンポーネント別セグメンテーション、実績および予測、2018年～2023年、2023年～2028年まで、2033年まで
  • 用途別のセグメンテーション、実績および予測、2018年～2023年、2023年～2028年まで、2033年まで
  • エンドユーザー別のセグメンテーション、実績および予測、2018年～2023年、2023年～2028年まで、2033年まで

第16章 英国の3Dバイオプリンティング市場

第17章 ドイツの3Dバイオプリンティング市場

第18章 フランスの3Dバイオプリンティング市場

第19章 イタリア 3Dバイオプリンティング市場

第20章 スペインの3Dバイオプリンティング市場

第21章 東欧の3Dバイオプリンティング市場

  • 概要
  • コンポーネント別セグメンテーション、実績および予測、2018年～2023年、2023年～2028年まで、2033年まで
  • 用途別のセグメンテーション、実績および予測、2018年～2023年、2023年～2028年まで、2033年まで
  • エンドユーザー別のセグメンテーション、実績および予測、2018年～2023年、2023年～2028年まで、2033年まで

第22章 ロシアの3Dバイオプリンティング市場

第23章 北米の3Dバイオプリンティング市場

  • 概要
  • コンポーネント別セグメンテーション、実績および予測、2018年～2023年、2023年～2028年まで、2033年まで
  • 用途別のセグメンテーション、実績および予測、2018年～2023年、2023年～2028年まで、2033年まで
  • エンドユーザー別のセグメンテーション、実績および予測、2018年～2023年、2023年～2028年まで、2033年まで

第24章 米国の3Dバイオプリンティング市場

第25章 カナダの3Dバイオプリンティング市場

第26章 南米の3Dバイオプリンティング市場

  • 概要
  • コンポーネント別セグメンテーション、実績および予測、2018年～2023年、2023年～2028年まで、2033年まで
  • 用途別のセグメンテーション、実績および予測、2018年～2023年、2023年～2028年まで、2033年まで
  • エンドユーザー別のセグメンテーション、実績および予測、2018年～2023年、2023年～2028年まで、2033年まで

第27章 ブラジルの3Dバイオプリンティング市場

第28章 中東の3Dバイオプリンティング市場

  • 概要
  • コンポーネント別セグメンテーション、実績および予測、2018年～2023年、2023年～2028年まで、2033年まで
  • 用途別のセグメンテーション、実績および予測、2018年～2023年、2023年～2028年まで、2033年まで
  • エンドユーザー別のセグメンテーション、実績および予測、2018年～2023年、2023年～2028年まで、2033年まで

第29章 アフリカの3Dバイオプリンティング市場

  • 概要
  • コンポーネント別セグメンテーション、実績および予測、2018年～2023年、2023年～2028年まで、2033年まで
  • 用途別のセグメンテーション、実績および予測、2018年～2023年、2023年～2028年まで、2033年まで
  • エンドユーザー別のセグメンテーション、実績および予測、2018年～2023年、2023年～2028年まで、2033年まで

第30章 3Dバイオプリンティング市場の競合情勢と企業プロファイル

  • 3Dバイオプリンティング市場の競合情勢
  • 3Dバイオプリンティング市場の企業プロファイル
    • Organovo Holdings Inc.
    • Allevi Inc.
    • Cellink AB
    • Aspect Biosystems Ltd.
    • 3D Systems Corporation

第31章 世界の3Dバイオプリンティング市場の競合ベンチマーキング

第32章 世界の3Dバイオプリンティング市場の競合ダッシュボード

第33章 3Dバイオプリンティング市場における主要な合併と買収

第34章 3Dバイオプリンティング市場の将来展望と可能性分析

第35章 付録

目次
Product Code: r9281

“3D Bioprinting Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on 3d bioprinting market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for 3d bioprinting? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The 3d bioprinting market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Component: 3D Bioprinters; Bioinks
  • 2) By Material: Living Cells; Hydrogels; Extracellular Matrices; Other Materials
  • 3) By Application: Research Applications; Clinical Application; Other Applications
  • 4) By End User: Research Organization And Academic Institutes; Biopharmaceuticals Companies; Hospitals; Other End Users
  • Companies Mentioned: Organovo Holdings Inc.; Allevi Inc.; Cellink AB; Aspect Biosystems Ltd.; 3D Systems Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

3D Bioprinting, a form of additive manufacturing, involves the layer-by-layer printing of live structures that emulate the behavior of living systems. This process utilizes cells and biocompatible materials, commonly referred to as bio-inks. The primary application of 3D bioprinting materials is in drug research, and more recently, in the creation of cell scaffolds for repairing damaged ligaments and joints.

The key components in 3D bioprinting include 3D bioprinters and bio-inks. 3D bioprinters employ three-dimensional technology along with biocompatible materials to replicate various body parts, facilitating the bioprinting of tissues, bones, organs, blood vessels, and biomedical components. The materials involved in the process encompass living cells, hydrogels, extracellular matrices, and others. The application of 3D bioprinting extends to research and clinical settings, among others, and finds implementation in diverse sectors such as research organizations, academic institutes, biopharmaceutical companies, hospitals, and more.

The 3D bioprinting market research report is one of a series of new reports from The Business Research Company that provides 3D bioprinting market statistics, including 3D bioprinting industry global market size, regional shares, competitors with a 3D bioprinting market share, detailed 3D bioprinting market segments, market trends and opportunities, and any further data you may need to thrive in the 3D bioprinting industry. This 3D bioprinting market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The 3d bioprinting market size has grown rapidly in recent years. It will grow from $1.59 billion in 2023 to $1.9 billion in 2024 at a compound annual growth rate (CAGR) of 19.8%. The growth observed during the historical period can be attributed to factors such as increased funding for research and development, the proliferation of chronic diseases, a shortage of organs for transplantation, a rise in pharmaceutical testing, and the expansion of tissue engineering initiatives.

The 3d bioprinting market size is expected to see exponential growth in the next few years. It will grow to $4.15 billion in 2028 at a compound annual growth rate (CAGR) of 21.6%. The anticipated growth in the forecast period can be attributed to advancements in healthcare, the increasing development of bio printed skin, a growing awareness among patients, and the aging population. Notable trends in this forecast period encompass the adoption of multi-material printing, advancements in vascularization techniques, the emergence of organ-on-a-chip technology, the customization of implants, and the exploration of bio fabrication in space.

Increased funding from both government and private sectors to support research activities in 3D bioprinting is projected to be a significant driving force behind the growth of the 3D bioprinting market in the coming forecast period. The expanding applications of 3D bioprinting in the healthcare sector have attracted substantial financial backing from these entities, offering vital financial and technical assistance across various developmental phases of 3D bioprinting techniques. Notably, in May 2021, Readily3d SA, a Swiss bioprinting company, secured a substantial funding of $600,000 from the European Union to advance its Tomolite 3D bioprinting technique, specifically aimed at developing a living miniature model of the pancreas. Similarly, in June 2020, the Australian Minister for Health provided Curtin University with a funding of $737,690 to innovate and optimize 3D technology for bioprinting skin tissue directly onto model wounds, as an initial step towards human skin restoration.

The anticipated rise in chronic diseases is set to be a driving factor in the prospective growth of the 3D bioprinting market. Chronic diseases, persisting over extended periods-typically three months or more, and often for a person's lifetime-have increasingly utilized 3D bioprinting for creating tissue models, aiding in chronic disease research and potential organ replacement therapies. For example, as per the World Health Organization's September 2022 report, approximately 41 million deaths globally annually, representing 74% of fatalities, are attributed to non-communicable diseases (NCDs) or chronic diseases. This alarming figure includes 17.9 million deaths from cardiovascular diseases, 9.3 million deaths from cancer, 4.1 million deaths from chronic respiratory diseases, and 2.0 million deaths from diabetes. Consequently, the upsurge in chronic diseases is a significant driver behind the growth of the 3D bioprinting market.

Key players in the 3D bioprinting market are introducing advanced, cost-effective next-generation bioprinters like the BIO MDX Series, focused on enhancing precision. The BIO MDX Series, the latest iteration of bioprinters, is tailor-made for high-throughput fabrication and precise 3D bioprinting within biomedical manufacturing. For instance, in March 2021, Cognex Corporation, a Swedish bioconvergence company, introduced the BIO MDX Series, optimized to meet the increasing demands in tissue engineering and regenerative medicine. As 3D bioprinting gains prominence among researchers, the necessity for heightened automation, accuracy, and reproducibility is underscored. This next-gen series, equipped with up to six printheads and integrated nanoliter and picoliter dispensing channels, caters to advanced cell-based technologies, addressing the field's evolving needs.

Artificial intelligence (AI) has seen an increasing integration within the 3D bioprinting market, contributing significantly to the creation of bio-tissues in a layer-by-layer approach from digital 3D models. Utilizing a combination of cells, growth factors, and biomaterials, AI, a technology branch emulating human behavior in machines, is employed in bioprinting to offer guidance on optimal printing parameters necessary for generating biocompatible tissues tailored to a patient's physiological structure. This involves data analysis and pattern recognition throughout the bioprinting process. For example, in June 2021, researchers from Queensland University of Technology's (QUT) Center in Transformative Biomimetics in Bioengineering, in collaboration with Oregon University, integrated AI and machine vision into 3D printers for manufacturing custom medical implants.

In May 2021, 3D Systems, a prominent US-based company specializing in 3D bioprinting technology, made public the acquisition of Allevi Inc., although the acquisition amount was undisclosed. Through this acquisition, 3D Systems aims to leverage Allevi's expertise in developing future applications, particularly in the long-term goal of human organ development, positioning itself as a market leader in bioprinting. Allevi Inc., a US-based firm, manufactures 3D bioprinters and bio-inks utilized by researchers within the field.

Major companies operating in the 3d bioprinting market include Organovo Holdings Inc., Allevi Inc., Cellink AB, Aspect Biosystems Ltd., 3D Systems Corporation, Cyfuse Biomedical KK, EnvisionTEC GmbH, Poietis SA, TeVido BioDevices, Nano3D Biosciences Inc., Digilab Inc., RegenHU Ltd., GeSiM mbH, Advanced Solutions Life Sciences LLC, Regenovo Biotechnology Co. Ltd., Regemat 3D S.L., Bio3D Technologies, Stratasys Ltd., ROKIT Healthcare Co. Ltd., Inventia Life Science Pvt. Ltd., Vivax Bio LLC, GE HealthCare Technologies Inc., 3D Biotek LLC, Nuclera Nucleics Ltd., 3D Fortify Inc., Carbon Inc., Divergent Technologies Inc., Markforged Inc., SprintRay Inc., 3D Bio Corp, 3D Bioprinting Solutions, BICO Group AB, CollPlant Biotechnologies Ltd., Shining 3D Tech Co. Ltd., 3Dynamic Systems Ltd., Modern Meadow Inc.

North America was the largest region in the 3D bioprinting market in 2023. The Asia-Pacific is expected to be the fastest-growing region in the 3D bioprinting market during the forecast period. The regions covered in the 3D bioprinting market report analysis are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The countries covered in the 3D bioprinting market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The 3D bioprinting market consists of sales of extrusion-based bioprinting, inkjet-based bioprinting, laser-assisted bioprinting, and stereolithography bioprinting. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. 3D Bioprinting Market Characteristics

3. 3D Bioprinting Market Trends And Strategies

4. 3D Bioprinting Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global 3D Bioprinting Market Size and Growth

  • 5.1. Global 3D Bioprinting Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global 3D Bioprinting Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global 3D Bioprinting Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. 3D Bioprinting Market Segmentation

  • 6.1. Global 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 3D Bioprinters
  • Bioinks
  • 6.2. Global 3D Bioprinting Market, Segmentation By Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Living Cells
  • Hydrogels
  • Extracellular Matrices
  • Other Materials
  • 6.3. Global 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Research Applications
  • Clinical Application
  • Other Applications
  • 6.4. Global 3D Bioprinting Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Research Organization And Academic Institutes
  • Biopharmaceuticals Companies
  • Hospitals
  • Other End Users

7. 3D Bioprinting Market Regional And Country Analysis

  • 7.1. Global 3D Bioprinting Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global 3D Bioprinting Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific 3D Bioprinting Market

  • 8.1. Asia-Pacific 3D Bioprinting Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific 3D Bioprinting Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China 3D Bioprinting Market

  • 9.1. China 3D Bioprinting Market Overview
  • 9.2. China 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China 3D Bioprinting Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India 3D Bioprinting Market

  • 10.1. India 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India 3D Bioprinting Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan 3D Bioprinting Market

  • 11.1. Japan 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.2. Japan 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan 3D Bioprinting Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia 3D Bioprinting Market

  • 12.1. Australia 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia 3D Bioprinting Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia 3D Bioprinting Market

  • 13.1. Indonesia 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia 3D Bioprinting Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea 3D Bioprinting Market

  • 14.1. South Korea 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.2. South Korea 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea 3D Bioprinting Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe 3D Bioprinting Market

  • 15.1. Western Europe 3D Bioprinting Market Overview
  • 15.2. Western Europe 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe 3D Bioprinting Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK 3D Bioprinting Market

  • 16.1. UK 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK 3D Bioprinting Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany 3D Bioprinting Market

  • 17.1. Germany 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany 3D Bioprinting Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France 3D Bioprinting Market

  • 18.5. France 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.6. France 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.7. France 3D Bioprinting Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy 3D Bioprinting Market

  • 19.9. Italy 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.10. Italy 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.11. Italy 3D Bioprinting Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain 3D Bioprinting Market

  • 20.13. Spain 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.14. Spain 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.15. Spain 3D Bioprinting Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe 3D Bioprinting Market

  • 21.1. Eastern Europe 3D Bioprinting Market Overview
  • 21.2. Eastern Europe 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe 3D Bioprinting Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia 3D Bioprinting Market

  • 22.1. Russia 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia 3D Bioprinting Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America 3D Bioprinting Market

  • 23.1. North America 3D Bioprinting Market Overview
  • 23.2. North America 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America 3D Bioprinting Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA 3D Bioprinting Market

  • 24.1. USA 3D Bioprinting Market Overview
  • 24.2. USA 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA 3D Bioprinting Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada 3D Bioprinting Market

  • 25.1. Canada 3D Bioprinting Market Overview
  • 25.2. Canada 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada 3D Bioprinting Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America 3D Bioprinting Market

  • 26.1. South America 3D Bioprinting Market Overview
  • 26.2. South America 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America 3D Bioprinting Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil 3D Bioprinting Market

  • 27.1. Brazil 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil 3D Bioprinting Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East 3D Bioprinting Market

  • 28.1. Middle East 3D Bioprinting Market Overview
  • 28.2. Middle East 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East 3D Bioprinting Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa 3D Bioprinting Market

  • 29.1. Africa 3D Bioprinting Market Overview
  • 29.2. Africa 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa 3D Bioprinting Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. 3D Bioprinting Market Competitive Landscape And Company Profiles

  • 30.1. 3D Bioprinting Market Competitive Landscape
  • 30.2. 3D Bioprinting Market Company Profiles
    • 30.2.1. Organovo Holdings Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Allevi Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Cellink AB
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Aspect Biosystems Ltd.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. 3D Systems Corporation
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Global 3D Bioprinting Market Competitive Benchmarking

32. Global 3D Bioprinting Market Competitive Dashboard

33. Key Mergers And Acquisitions In The 3D Bioprinting Market

34. 3D Bioprinting Market Future Outlook and Potential Analysis

  • 34.1 3D Bioprinting Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 3D Bioprinting Market In 2028 - Segments Offering Most New Opportunities
  • 34.3 3D Bioprinting Market In 2028 - Growth Strategies
  • 34.3.1 Market Trend Based Strategies
  • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35.4. Research Inquiries
  • 35.5. The Business Research Company
  • 35.6. Copyright And Disclaimer